×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Akoya Biosciences Inc. (AKYA) NASDAQ

$2.36 0.13 (5.83%)

Market Cap: $116.55M

As of 06/21/24 04:00 PM EDT. Market closed.

(AKYA)

Akoya Biosciences Inc. (AKYA)
NASDAQ

$2.36
0.13 (5.83%)

Market Cap: $116.55M

As of 06/21/24 04:00 PM EDT. Market closed.

Add to Portfolio

akoya biosciences is developing a novel high-parameter tissue analysis platform, at an order of magnitude beyond what is currently possible. our codex (tm) (co-detection by indexing) system enables deep proteomic profiling.​..all on your existing microscope​. if you are a scientist or software engineer interested in revolutionizing the science of imaging, then akoya is the place for you. ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Address
.
PRICE CHART FOR AKOYA BIOSCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.50
Previous Close
$2.23
Days Range
$2.28 - $2.59
52 week range
$1.88 - $7.68
Volume
929,971
Avg. Volume (30 days)
364,995
Market Cap
$116.55M
Dividend Yield
-
P/E
(1.71)
Shares Outstanding
49,386,247
Open
$2.50
Previous Close
$2.23
Days Range
$2.28 - $2.59
52 week range
$1.88 - $7.68
Volume
929,971
Avg. Volume (30 days)
364,995
Market Cap
$116.55M
Dividend Yield
-
P/E
(1.71)
Shares Outstanding
49,386,247
FINANCIAL STATEMENTS FOR AKOYA BIOSCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AKOYA BIOSCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
McKelligon BrianPresident and CEOJun 11, 2024 Option Exercise$0.307,5002,273232,233Jun 12, 2024, 04:01 PM
McKelligon BrianPresident and CEOJun 11, 2024 Sale$2.087,50015,630224,733Jun 12, 2024, 04:01 PM
McKelligon BrianPresident and CEOJun 06, 2024 Option Exercise$0.307,5002,273232,233Jun 07, 2024, 09:56 PM
McKelligon BrianPresident and CEOJun 06, 2024 Sale$2.017,50015,064224,733Jun 07, 2024, 09:56 PM
Ek John FrederickCFOApr 01, 2024 Option Exercise$4.5614,27265,080180,728Apr 02, 2024, 04:41 PM
Pla FredericChief Operating OfficerMar 23, 2024 Option Exercise$4.792,0069,609101,500Mar 25, 2024, 05:16 PM
Ramachandran Niro Ph.DChief Business OfficerMar 23, 2024 Option Exercise$4.792,0069,609207,924Mar 25, 2024, 05:14 PM
McKelligon BrianPresident and CEOMar 23, 2024 Option Exercise$4.797,13534,177224,733Mar 25, 2024, 05:12 PM
McKelligon BrianPresident and CEOMar 20, 2024 Option Exercise$0.307,5002,273239,368Mar 22, 2024, 05:54 PM
McKelligon BrianPresident and CEOMar 20, 2024 Sale$4.977,50037,243231,868Mar 22, 2024, 05:54 PM
McKelligon BrianPresident and CEOMar 13, 2024 Option Exercise$0.307,5002,273239,368Mar 22, 2024, 05:51 PM
McKelligon BrianPresident and CEOMar 13, 2024 Sale$4.947,50037,043231,868Mar 22, 2024, 05:51 PM
McKelligon BrianPresident and CEOMar 13, 2024 Sale$4.947,50037,035224,368Mar 14, 2024, 08:41 PM
McKelligon BrianPresident and CEOMar 01, 2024 Option Exercise$6.038,19549,416231,868Mar 04, 2024, 06:01 AM
Kamocsay JenniferGeneral CounselMar 01, 2024 Option Exercise$6.033,28319,79699,217Mar 01, 2024, 09:53 PM
Pla FredericChief Operating OfficerMar 01, 2024 Option Exercise$6.032,04912,355103,506Mar 01, 2024, 09:52 PM
Ramachandran Niro Ph.DChief Business OfficerMar 01, 2024 Option Exercise$6.032,30513,899209,930Mar 01, 2024, 09:52 PM
McKelligon BrianPresident and CEOMar 01, 2024 Option Exercise$6.0310,24461,771231,868Mar 01, 2024, 09:21 PM
McKelligon BrianPresident and CEODec 19, 2023 Option Exercise$0.307,5002,273160,063Dec 20, 2023, 07:16 PM
McKelligon BrianPresident and CEODec 19, 2023 Sale$4.487,50033,565152,563Dec 20, 2023, 07:16 PM
McKelligon BrianPresident and CEODec 12, 2023 Option Exercise$0.307,5002,273160,063Dec 14, 2023, 04:24 PM
McKelligon BrianPresident and CEODec 12, 2023 Sale$4.257,50031,871152,563Dec 14, 2023, 04:24 PM
Pla FredericChief Operating OfficerSep 07, 2023 Buy$4.6020,00092,01420,000Sep 11, 2023, 04:00 PM
Ek John FrederickCFOJun 12, 2023 Buy$5.0020,000100,00020,000Jun 12, 2023, 06:18 PM
LAI GOLDMAN MYLADirectorJun 12, 2023 Buy$5.0020,000100,00020,000Jun 12, 2023, 06:18 PM
Mendel ScottDirectorJun 12, 2023 Buy$5.0020,000100,00028,500Jun 12, 2023, 06:17 PM
Winkler MatthewDirectorJun 12, 2023 Buy$5.00203,3881,016,940984,513Jun 12, 2023, 06:16 PM
SHEPLER ROBERT GDirectorJun 12, 2023 Buy$5.00120,000600,000369,592Jun 12, 2023, 06:16 PM
Raffin Thomas A.DirectorJun 12, 2023 Buy$5.002,000,00010,000,00015,937,535Jun 12, 2023, 06:15 PM
Raffin Thomas A.DirectorJun 12, 2023 Buy$5.0020,000100,000234,592Jun 12, 2023, 06:15 PM
McKelligon BrianPresident/CEOJun 06, 2023 Option Exercise$0.305,0001,515157,563Jun 06, 2023, 09:45 PM
McKelligon BrianPresident/CEOJun 06, 2023 Sale$5.715,00028,537152,563Jun 06, 2023, 09:45 PM
Nolan Garry Ph.D.DirectorDec 13, 2022 Sale$13.251001,325555,084Mar 27, 2023, 08:12 PM
Ramachandran Niro Ph.DChief Business OfficerMar 23, 2023 Option Exercise$7.691,94514,957177,235Mar 27, 2023, 08:09 PM
Pla FredericChief Operating OfficerMar 23, 2023 Option Exercise$7.691,94514,95740,555Mar 27, 2023, 08:07 PM
McKelligon BrianPresident/CEOMar 23, 2023 Option Exercise$7.697,43757,191152,563Mar 27, 2023, 08:05 PM
McKelligon BrianPresident/CEOMar 14, 2023 Option Exercise$0.305,0001,515165,000Mar 16, 2023, 04:20 PM
McKelligon BrianPresident/CEOMar 14, 2023 Sale$9.175,00045,852160,226Mar 16, 2023, 04:20 PM
Ramachandran Niro Ph.DChief Business OfficerFeb 15, 2023 Option Exercise$0.9134,00030,940156,680Feb 17, 2023, 05:10 PM
DRISCOLL JOSEPHChief Financial OfficerDec 22, 2022 Option Exercise$0.44250,000110,000262,500Dec 27, 2022, 04:05 PM
SCHNETTLER THOMAS PDirectorDec 13, 2022 Sale$13.0371,050925,7812,742,721Dec 20, 2022, 04:02 PM
DRISCOLL JOSEPHChief Financial OfficerDec 14, 2022 Option Exercise$0.4424,61310,83027,074Dec 16, 2022, 05:59 PM
DRISCOLL JOSEPHChief Financial OfficerDec 14, 2022 Sale$12.5424,613308,70612,500Dec 16, 2022, 05:59 PM
Nolan Garry Ph.D.DirectorDec 13, 2021 Sale$13.251001,325555,084Dec 15, 2022, 07:07 PM
McKelligon BrianPresident/CEODec 06, 2022 Option Exercise$0.305,0001,51585,000Dec 08, 2022, 04:01 PM
McKelligon BrianPresident/CEODec 06, 2022 Sale$12.085,00060,41580,000Dec 08, 2022, 04:01 PM
Nolan Garry Ph.D.DirectorDec 02, 2022 Sale$13.251,10014,575591,978Dec 06, 2022, 06:29 PM
Nolan Garry Ph.D.DirectorDec 01, 2022 Sale$13.365,00066,788593,078Dec 02, 2022, 04:00 PM
Nolan Garry Ph.D.DirectorNov 16, 2022 Sale$13.253003,976598,078Nov 17, 2022, 06:21 PM
Nolan Garry Ph.D.DirectorNov 10, 2022 Sale$13.313,81050,705618,978Nov 14, 2022, 06:43 PM
Nolan Garry Ph.D.DirectorNov 14, 2022 Sale$13.286007,966598,378Nov 14, 2022, 06:43 PM
Nolan Garry Ph.D.DirectorNov 11, 2022 Sale$13.2920,000265,858598,978Nov 14, 2022, 06:43 PM
Nolan Garry Ph.D.DirectorSep 14, 2022 Sale$13.268,305110,084622,788Sep 16, 2022, 07:07 PM
Nolan Garry Ph.D.DirectorSep 12, 2022 Sale$13.301,80023,944631,093Sep 13, 2022, 04:07 PM
Nolan Garry Ph.D.DirectorSep 09, 2022 Sale$13.3122,191295,338632,893Sep 13, 2022, 04:07 PM
McKelligon BrianPresident/CEOSep 07, 2022 Option Exercise$0.305,0001,51585,000Sep 09, 2022, 04:00 PM
McKelligon BrianPresident/CEOSep 07, 2022 Sale$12.835,00064,17080,000Sep 09, 2022, 04:00 PM
Ramachandran Niro Ph.DChief Business OfficerApr 13, 2022 Option Exercise$0.9175,10768,347122,680Apr 14, 2022, 03:23 PM
Nolan Garry Ph.D.DirectorDec 09, 2021 Sale$12.6725,000316,762655,084Dec 13, 2021, 06:06 PM
Ramachandran Niro Ph.DChief Business OfficerNov 22, 2021 Buy$13.1325,000328,29225,073Nov 22, 2021, 08:27 PM
Ramachandran Niro Ph.DChief Business OfficerNov 19, 2021 Buy$12.857393873Nov 22, 2021, 08:27 PM
Mendel ScottDirectorNov 19, 2021 Buy$13.168,500111,8608,500Nov 19, 2021, 12:55 PM
SHEPLER ROBERT GDirectorNov 18, 2021 Buy$12.6035,000441,00535,000Nov 18, 2021, 09:08 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
McKelligon BrianPresident and CEO06/11/20242,273
McKelligon BrianPresident and CEO06/11/202415,630
McKelligon BrianPresident and CEO06/06/20242,273
McKelligon BrianPresident and CEO06/06/202415,064
Ek John FrederickCFO04/01/202465,080
Pla FredericChief Operating Officer03/23/20249,609
Ramachandran Niro Ph.DChief Business Officer03/23/20249,609
McKelligon BrianPresident and CEO03/23/202434,177
McKelligon BrianPresident and CEO03/20/20242,273
McKelligon BrianPresident and CEO03/20/202437,243
McKelligon BrianPresident and CEO03/13/20242,273
McKelligon BrianPresident and CEO03/13/202437,043
McKelligon BrianPresident and CEO03/13/202437,035
McKelligon BrianPresident and CEO03/01/202449,416
Kamocsay JenniferGeneral Counsel03/01/202419,796
Pla FredericChief Operating Officer03/01/202412,355
Ramachandran Niro Ph.DChief Business Officer03/01/202413,899
McKelligon BrianPresident and CEO03/01/202461,771
McKelligon BrianPresident and CEO12/19/20232,273
McKelligon BrianPresident and CEO12/19/202333,565
McKelligon BrianPresident and CEO12/12/20232,273
McKelligon BrianPresident and CEO12/12/202331,871
Pla FredericChief Operating Officer09/07/202392,014
Ek John FrederickCFO06/12/2023100,000
LAI GOLDMAN MYLADirector06/12/2023100,000
Mendel ScottDirector06/12/2023100,000
Winkler MatthewDirector06/12/20231,016,940
SHEPLER ROBERT GDirector06/12/2023600,000
Raffin Thomas A.Director06/12/202310,000,000
Raffin Thomas A.Director06/12/2023100,000
McKelligon BrianPresident/CEO06/06/20231,515
McKelligon BrianPresident/CEO06/06/202328,537
Nolan Garry Ph.D.Director12/13/20221,325
Ramachandran Niro Ph.DChief Business Officer03/23/202314,957
Pla FredericChief Operating Officer03/23/202314,957
McKelligon BrianPresident/CEO03/23/202357,191
McKelligon BrianPresident/CEO03/14/20231,515
McKelligon BrianPresident/CEO03/14/202345,852
Ramachandran Niro Ph.DChief Business Officer02/15/202330,940
DRISCOLL JOSEPHChief Financial Officer12/22/2022110,000
SCHNETTLER THOMAS PDirector12/13/2022925,781
DRISCOLL JOSEPHChief Financial Officer12/14/202210,830
DRISCOLL JOSEPHChief Financial Officer12/14/2022308,706
Nolan Garry Ph.D.Director12/13/20211,325
McKelligon BrianPresident/CEO12/06/20221,515
McKelligon BrianPresident/CEO12/06/202260,415
Nolan Garry Ph.D.Director12/02/202214,575
Nolan Garry Ph.D.Director12/01/202266,788
Nolan Garry Ph.D.Director11/16/20223,976
Nolan Garry Ph.D.Director11/10/202250,705
Nolan Garry Ph.D.Director11/14/20227,966
Nolan Garry Ph.D.Director11/11/2022265,858
Nolan Garry Ph.D.Director09/14/2022110,084
Nolan Garry Ph.D.Director09/12/202223,944
Nolan Garry Ph.D.Director09/09/2022295,338
McKelligon BrianPresident/CEO09/07/20221,515
McKelligon BrianPresident/CEO09/07/202264,170
Ramachandran Niro Ph.DChief Business Officer04/13/202268,347
Nolan Garry Ph.D.Director12/09/2021316,762
Ramachandran Niro Ph.DChief Business Officer11/22/2021328,292
Ramachandran Niro Ph.DChief Business Officer11/19/2021938
Mendel ScottDirector11/19/2021111,860
SHEPLER ROBERT GDirector11/18/2021441,005
Load More Insider Transactions
FUNDS WITH A POSITION IN AKOYA BIOSCIENCES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.1,347,5390.00015%-1.8%Other
GEODE CAPITAL MANAGEMENT, LLC514,0490.00022%3.19%Other
RENAISSANCE TECHNOLOGIES LLC50,7000.00037%6.96%Other
CHANGE IN SHARES OUTSTANDING FOR AKOYA BIOSCIENCES INC
STOCK BUYBACKS FOR AKOYA BIOSCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
-0.99%
1Q
03/31/2024
09/30/2023
0.43%
2Q
03/31/2024
06/30/2023
21.03%
3Q
03/31/2024
03/31/2023
28.34%
4Q
03/31/2024
12/31/2022
29.42%
5Q
03/31/2024
09/30/2022
29.78%
6Q
03/31/2024
06/30/2022
30.78%
7Q
03/31/2024
03/31/2022
31.29%
8Q
03/31/2024
12/31/2021
82.88%
9Q
03/31/2024
09/30/2021
32.36%
10Q
03/31/2024
06/30/2021
64.10%
11Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
-0.99%
1Q
09/30/2023
0.43%
2Q
06/30/2023
21.03%
3Q
03/31/2023
28.34%
4Q
12/31/2022
29.42%
5Q
09/30/2022
29.78%
6Q
06/30/2022
30.78%
7Q
03/31/2022
31.29%
8Q
12/31/2021
82.88%
9Q
09/30/2021
32.36%
10Q
06/30/2021
64.10%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AKOYA BIOSCIENCES INC
LOADING...